NEW YORK – Quest Diagnostics said today it has entered an agreement to provide Catholic Health Services of Long Island with laboratory management services and reference testing.
Under the agreement, Quest will provide CHS with lab testing as well as management of lab equipment, supplies, and procurement processes. The agreement covers six CHS hospitals, a core lab, a cancer center, and an infusion center.
Financial and other terms of the deal were not disclosed.
According to Secaucus, New Jersey-based Quest, CHS has 24 percent market share on Long Island.
"Today's health care is constantly evolving, presenting challenges and opportunities for health systems like ours," Dennis Verzi, CHS' COO, said in a statement. "We chose Quest Diagnostics to benefit from their innovative technologies, reach and diagnostic capabilities. Most importantly, this new venture will allow us to remain focused on improving patient care and outcomes on Long Island, while teaming up with a leader in the field who has access to the most sophisticated diagnostic equipment available."
"As part of our strategy to accelerate growth and drive operational excellence, Quest is collaborating with an increasing number of leading integrated health care delivery systems like Catholic Health Services, which are looking to focus on their core business by taking advantage of our expertise, innovation and scale, said Steve Rusckowski, Quest's chairman, president, and CEO.